Search results
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 3 days agoPfizer also faces the expiration of patents on some of its biggest drugs, including breast cancer...
Here's Why Pfizer (PFE) is a Strong Momentum Stock
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) New York-based Pfizer markets a wide range of drugs and vaccines. Pfizer’s Biopharma reporting segment ...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 23 hours agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoExcluding that, Paxlovid sales still topped expectations. Comirnaty, the Covid vaccine Pfizer...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoWe are proud of the positive impact we achieved around the world with our deep capabilities and global scale. Through the first three months of the year,...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expect
Guru Focus· 4 days agoPfizer Inc (PFE, Financial) released its 8-K filing on May 1, 2024, disclosing the financial outcomes for the first quarter of 2024. Pfizer, a leading global ...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 5 days agoThe drugmaker has faced some big challenges and has more on the way. Pfizer's revenue in 2023 fell...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 3 days agoPfizer Chief Executive Albert Bourla said in an interview Wednesday he was encouraged but that the company's stock is undervalued.
The two sides of AstraZeneca’s vaccine ‘miracle’
Daily Telegraph· 4 days agoAstraZeneca had been unable to identify the cause of the clots and the Government bought its Covid vaccines for the next year’s rollout from rivals. In...
